FibroBiologics, Inc. financial data

Symbol
FBLG on Nasdaq
Industry
Pharmaceutical Preparations
Location
455 E. Medical Center Blvd, Suite 300, Houston, TX
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 7, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 35.2M shares
Weighted Average Number of Shares Outstanding, Basic 32.7M shares +15.9%
Weighted Average Number of Shares Outstanding, Diluted 32.7M shares +15.9%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 975K USD +78.2%
General and Administrative Expense 2.25M USD +45.5%
Operating Income (Loss) -3.22M USD -54%
Net Income (Loss) Attributable to Parent 898K USD
Earnings Per Share, Basic 0.03 USD/shares
Earnings Per Share, Diluted 0.03 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.97M USD
Other Assets, Current 18K USD
Assets, Current 6.51M USD
Property, Plant and Equipment, Net 799K USD
Operating Lease, Right-of-Use Asset 1.6M USD
Assets 8.91M USD
Contract with Customer, Liability, Current 1.5M USD
Liabilities, Current 10.1M USD
Operating Lease, Liability, Noncurrent 1.17M USD
Liabilities 11.3M USD
Retained Earnings (Accumulated Deficit) -31.9M USD
Stockholders' Equity Attributable to Parent -2.39M USD -121%
Liabilities and Equity 8.91M USD

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.28M USD -110%
Net Cash Provided by (Used in) Financing Activities 3.28M USD -77.5%
Net Cash Provided by (Used in) Investing Activities -8K USD +85.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.01M USD -108%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.97M USD -47.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 4K USD
Operating Lease, Liability 1.55M USD
Depreciation 37K USD +1750%
Payments to Acquire Property, Plant, and Equipment 8K USD -85.7%
Lessee, Operating Lease, Liability, to be Paid 1.76M USD
Property, Plant and Equipment, Gross 918K USD
Operating Lease, Liability, Current 382K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 544K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 488K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 210K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 509K USD
Preferred Stock, Shares Authorized 20M shares
Additional Paid in Capital 29.5M USD
Share-based Payment Arrangement, Expense 579K USD +29.2%
Interest Expense 5K USD -50%